For the first time, researchers have reported progress in regenerating damaged auditory nerves through regenerative cell therapy, moving beyond symptom management to actual biological repair of hearing structures. Early clinical efforts suggest that biological restoration of hearing may be possible if safety and effectiveness are confirmed in future studies.
Background
Sensorineural hearing loss is the most common type of permanent hearing impairment. It occurs when the sensory hair cells in the cochlea or the auditory nerve fibers that connect the inner ear to the brain are damaged by aging, loud noise, infection, or genetic factors. Current treatments, such as hearing aids and cochlear implants, improve hearing function but do not repair the underlying cellular damage.
A First-in-Human Regenerative Cell Therapy Trial
Researchers at the University of Sheffield in the United Kingdom have begun the first human clinical trial of a regenerative cell therapy designed to repair the inner ear’s damaged nerve pathways. This therapy, developed by a spin-out company called Rinri Therapeutics, uses stem cell–derived cells that are programmed to mature into auditory neurons, which are the nerve cells essential for transmitting sound signals from the ear to the brain.
The approved Phase 1 trial will test the safety and early effectiveness of this approach in adults with severe hearing loss due to damage to auditory neurons. Half of the participants will receive the stem cell therapy along with cochlear implant surgery, and the other half will receive the implant alone. The goal is to determine whether the injected cells can integrate into the inner ear and contribute to true biological hearing restoration.
How the Therapy Works
The therapy, often referred to as Rincell-1, is administered directly into the inner ear during cochlear implant surgery. Researchers use a specialized surgical method to place the cells precisely where they are most needed. These cells are derived from stem cells and are conditioned to develop into functional auditory neurons once in the inner ear environment.
If successful, this approach could allow the auditory nerve to regenerate and improve the performance of cochlear implants, or even offer a route to natural hearing without devices.
Broader Research Context
Scientists are also actively working on related regenerative strategies, including:
- Stem cell delivery to enhance cochlear implant outcomes in animal models, showing increased spiral ganglion neuron numbers and better signal responses when cells are delivered alongside electrical stimulation.
- Cell and gene therapy approaches aimed at regenerating inner ear sensory hair cells, which are critical for detecting sound. Various drug and gene techniques are showing promise in lab and animal studies.
What This Means for the Future
These early clinical efforts represent a potential turning point in how hearing loss might be treated. If the stem cell therapy proves safe and effective, and subsequent larger trials confirm its benefits, there may be a path to biological restoration of hearing, not just temporary improvement. This could have global impact for hundreds of millions of people who currently live with permanent hearing loss.
For now, the research remains in early stages. Patient outcomes from the ongoing trials will be critical in determining whether regenerative therapies can shift from experimental to mainstream treatment.
